Диссертация (1140048), страница 18
Текст из файла (страница 18)
Circ J. 2013;77(3):697-704.110113. Levin E.R., Gardner D.G., Samson W.K. Natriuretic peptides. New Engl. J.Med. 1998.-Vol. 339, № 5.-P. 321-328.114. Levy S Factors predisposing to the development of atrial fibrillation // PacingClin. Electrophysiol. 1997. - Vol.20(10 Pt 2). - P.
2670-2674.115. Li D., Karen S., Leung T.K., Nattel S. Promotion of atrial fibrillation by heartfailure in dogs: atrial remodeling of a different sort. // Circulation. 1999, Vol. 100.Р. 87–95.116. Liao J., Khalid Z., Scallan C., et al. Atrial fibrillation in stroke- free patients isassociated with memory impairment and hippocampal atrophy // Eur. Heart J –2008 – Vol. 2008.
Jul 29.117. Lobo T.J., Pachon C.T., Pachon J.C., et al. Atrial Fibrillation Ablation inSystolic Dysfunction: Clinical and Echocardiographic Outcomes. Arq BrasCardiol. 2014 Nov 11;0.118. Mabuchi N., Tsutamoto T., Maeda K., Kinoshita M.
Plasma cardiacnatriuretic peptides as biochemical markers of recurrence of atrial fibrillation inpatients with mild congestive heart failure.// Jpn. Circ. J. -2000.- Vol. 64,- № 10.P. 765-71.119. Madamanchi C., Alhosaini H., Sumida A., et al. Obesity and natriureticpeptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heartfailure. Int J Cardiol. 2014 Oct 20;176(3):611-7.120. Mak G.S., DeMaria A., Clopton P., Maisel A.S.
Utility of B-natriureticpeptide in the evaluation of left ventricular diastolic function: comparison withtissue Doppler imaging recordings. Am Heart J. 2004 Nov;148(5):895-902.121. Malouf J., Kanagala R., Al Atawi F. et al. High sensitivity C-reactive protein:a novel predictor for recurrence of atrial fibrillation after successful cardioversion// J. Am.
Coll. Cardiol. – 2005. – [Vol.] 46. – P. 1284–1287.122. Manning, W. J. Pulsed Doppler evaluation of atrial mechanical function afterelectrical cardioversion of atrial fibrillation / W. J. Manning, D. E. Leeman, P. J.Gotch // J. Am. Coll. Cardiol. 1989. - Vol. 13. - P. 617-23.111123. Manning W.J. et al. Impaired left atrial mechanical function aftercardioversion: relation to the duration of atrial fibrillation. // J.
Am. Coll.Cardiol.1994.-Vol. 23.-P. 1535.124. Manola S., Pavlović N., Radeljić V., et al. B-type natriuretic peptide aspredictor of heart failure in patients with acute ST elevation myocardial infarction,single-vessel disease, and complete revascularization: follow-up study.
Croat MedJ. 2009 Oct;50(5):449-54.125. Mattioli, A. V. Clinical and echocardiographic features influencing recoveryof atrial function after cardioversion of atrial fibrillation / A. V. Mattioli, A.Castelli, A. Andria // Am. J. Cardiol. 1998. - Vol.
82. - P. 1368- 1371.126. T. D. Callaban et al. Catheter ablation of atrial fibrillation. // Cardiol. Clin.2009. Vol. 27.-P. 163-178.127. Matunović R., Stojanović A., Mijailović Z., et al. Natriuretic peptides andmultimarkerapproachtoriskstratificationofpatientswith acute coronary syndromes. Med Pregl. 2006 May-Jun;59(5-6):248-52.128. Masson S., Latini R. Amino-terminal pro-B-type natriuretic peptides andprognosis in chronic heart failure.
Am J Cardiol. 2008 Feb 4;101(3A):56-60.129. McDonagh T.A., Morton J.J., Baumann M. et. al. N-terminal Pro-BNP andprognosis of left ventricular dysfunction in population based study. Eur Heart J. 2000. Vol. 21. — P.151-155.130. McGann C, Akoum N, Patel A, Kholmovski E, et al. Atrial FibrillationAblation Outcome Is Predicted by Left Atrial Remodeling on MRI. Circ ArrhythmElectrophysiol.
2013131. Melduni R.M., Cullen M.W. Role of left ventricular diastolic dysfunction inPredicting atrial fibrillation recurrence after successful electrical cardioversion. JAtr Fibrillation 2012 Dec; 5(4): 87-94.132. Menke J., Lüthje L., Kastrup A., Larsen J. Thromboembolism in atrialfibrillation. Am J Cardiol. 2010 Feb 15;105(4):502-10.112133. Mitusch R. Garber M, Schmucker G. Relation of left atrial appendagefunction to the duration and reversibility of not valvular atrial fibrillation. // Am JCard., 1995, vol 75, р.994-99134. Miyasaka Y., Barnes M.E., Bailey K.R., et al.
Mortality trends in patientsdiagnosed with first atrial fibrillation: a 21-year community based study// J.Am.Coll. Cardiol. – 2007. – Vol.49. – P.986- 992.135. Morillo C, Klein G, Jones D. Chronic rapid atrial pacing structural,functional, and electrophysiological characteristics of a new model of sustainedatrial fibrillation. Circulation 1995;91:1588-1595.136.
Nakatani B.T., Minicucci M.F., Okoshi K., Politi Okoshi M.Tachycardia-induced cardiomyopathy. BMJ Case Rep. 2012 Sep 21;2012.137. Nazir S.A., Lab V.J. Mechanoelectric feedback in the atrium of the isolatedguinea-pig heart // Cardiovasc. Res. 1996. - Vol.32(1). - P. 112-119 .138. Ngo L., Bissett J.K., Winters C.J., Vesely D.L. Plasma prohormone atrialnatriuretic peptides 1-98 and 31-67 increasewith supraventricular and ventriculararrhythmias.
Amer. J. Med. Sci. 1990. - Vol. 300. - P. 71-77.139. Nieminen MS, Brutsaert D, Dickstein K et al. EuroHeart Failure Survey II(EHFS II): a survey on hospitalized acute heart failure patients: description ofpopulation. Eur Heart J. 2006;27 (22):2725–2736.140. Nieuwlaat R., Dinh T, Olsson S.B. et al Should be abandon the commonpractice of withholding oral coagulation in paroxysmal atrial fibrillation?// Eur.Heart J – 2008 – Vol.
29 – P. 915-922.141. Ninio D.M., Saint D.A. The role of stretch-activated channels in atrialfibrillation and the impact of intracellular acidosis. Prog Biophys Mol Biol. 2008Jun-Jul;97(2-3):401-16.142. Nishikimi Т., Yoshihara F., Jshikawa K. et al. Relationship between leftventricular geometry and natriuretic peptide levels in essential hypertension.Hypertension 1996; 28: 22-30.113143.
Nishikimi T. Do plasma levels of brain natriuretic peptide (BNP) and Nterminal proBNP (NT-proBNP) increase in diastolic dysfunction as well as insystolic dysfunction? Circ J. 2012;76(11):2540-1.144. Opolski G., Torbicki A., Kosior D.A. et al.
Rate control vs rhythm control inpatients with nonvalvular persistent atrial fibrillation: the results of thePolish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest2004;126:476—486.145.Panagopoulou V., Deftereos S., Kossyvakis C., et al. NTproBNP: animportant biomarker in cardiac diseases. Curr Top Med Chem. 2013;13(2):82-94.146. Parekh N., Maisel A.S. Utility of B-natriuretic peptide in the evaluation of leftventricular diastolic function and diastolic heart failure. Curr Opin Cardiol. 2009Mar;24(2):155-60.147. Pillarisetti J., Reddy N., Biria M., et al.
Elevated brain natriuretic peptidelevel in patients undergoing atrial fibrillation ablation: is it a predictor of failedablation or a mere function of atrial rhythm and rate at a point in time? J IntervCard Electrophysiol. 2014 Aug;40(2):161-8.148. Psychari S., Apostolou T., Sinos L. et al. Relation of elevated C-reactiveprotein and interleukin46 levels to left atrial size and duration of episodesin patients with atrial fibrillation // Am. J.
Cardiol. 2005. – [Vol.] 95. – P. 764–767.149. Redfield M. Treating diastolic heart failure with AGE crosslink breakers:thinking outside the heart failure box // J. Card. Fail. – 2005. – [Vol.] 11.–P. 196–199.150. Rienstra M., Damman K., Mulder B.A., et al. Beta-blockers and outcomes inHF and AF. JACC 2013; (1): 21-8.151. Rossi A., Enriquez-Sarano M., Burnett J.C., et al.
Natriuretic peptide levelsin atrial fibrillation. // J. Am. Coll. Cardiol. 2000. - № 35. -P. 1256-1262.152. Roy D., Talajic M.,. Nattel S., et al. Rhythm control versus rate control foratrial fibrillation and heart failure. N Engl J Med. 2008 Jun 19;358(25):2667-77.114153. Ryding A.D., Kumar S, Worthington AM, et al. Prognostic value of brainnatriuretic peptide in noncardiac surgery: a meta-analysis. Anesthesiology. 2009Aug;111(2):311-9.154.
Sachs F. Modeling mechanical-electrical transduction in the heart // CellMechanics and Cellular Engineering/ Ed. Mow V.C. et.al. N.Y.: Springer-Verlag.1994. - P. 308-328.155. Saksena S., Slee A., Waldo A.L., et al. Cardiovascular outcomes inthe AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of RhythmManagement). An assessment of individual antiarrhythmic drug therapiescompared with rate control with propensity score-matched analyses. J Am CollCardiol. 2011 Nov 1;58(19):1975-85.156. Santamarina E, Alvarez Sabín J.
Social impact of stroke due to atrialfibrillation. Neurologia. 2012 Mar;27 Suppl 1:10-4.157. Sato R., Koumi S. Characterisation of stretch-activated chloride channel inisolated human atrial myocytes // J. Membs. Biology. - 1998. - Vol. 163. - P. 6776.158. Savarese G., Musella F., D'Amore C., et al.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
